Cargando…

Fulminant myocarditis with COVID‐19 infection having normal C‐reactive protein and serial magnetic resonance follow‐up

A 44‐year‐old woman who was quarantined for 5 days after the diagnosis of coronavirus disease of 2019 (COVID‐19) was transferred to our hospital with the complaint of chest pain. The patient was unvaccinated. Electrocardiography revealed ST elevation in the lateral leads. Echocardiographic biventric...

Descripción completa

Detalles Bibliográficos
Autores principales: Usui, Eisuke, Nagaoka, Eiki, Ikeda, Hiroshi, Ohmori, Mari, Tao, Susumu, Yonetsu, Taishi, Maejima, Yasuhiro, Arai, Hirokuni, Amemiya, Kisaki, Ikeda, Yoshihiko, Sasano, Tetsuo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10053182/
https://www.ncbi.nlm.nih.gov/pubmed/36401586
http://dx.doi.org/10.1002/ehf2.14228
_version_ 1785015351445028864
author Usui, Eisuke
Nagaoka, Eiki
Ikeda, Hiroshi
Ohmori, Mari
Tao, Susumu
Yonetsu, Taishi
Maejima, Yasuhiro
Arai, Hirokuni
Amemiya, Kisaki
Ikeda, Yoshihiko
Sasano, Tetsuo
author_facet Usui, Eisuke
Nagaoka, Eiki
Ikeda, Hiroshi
Ohmori, Mari
Tao, Susumu
Yonetsu, Taishi
Maejima, Yasuhiro
Arai, Hirokuni
Amemiya, Kisaki
Ikeda, Yoshihiko
Sasano, Tetsuo
author_sort Usui, Eisuke
collection PubMed
description A 44‐year‐old woman who was quarantined for 5 days after the diagnosis of coronavirus disease of 2019 (COVID‐19) was transferred to our hospital with the complaint of chest pain. The patient was unvaccinated. Electrocardiography revealed ST elevation in the lateral leads. Echocardiographic biventricular dysfunction with oedematous wall thickening was identified. Cardiac enzyme levels were elevated; however, C‐reactive protein (CRP) levels, and the coronary angiogram were normal. The patient required mechanical circulatory support to stabilize haemodynamics and was treated with remdesivir, baricitinib, and intravenous methylprednisolone. She recovered after 13 days of mechanical support. Serial cardiac magnetic resonance imaging revealed acute myocardial oedema and subsequent fibrosis. An endomyocardial biopsy on admission showed mild interstitial inflammatory infiltrates with endomyocardial fibrous thickening and mild interstitial fibrosis of the myocardium. Normal CRP levels suggested minor involvement of interleukin (IL)‐6, supporting the efficacy of baricitinib.
format Online
Article
Text
id pubmed-10053182
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-100531822023-03-30 Fulminant myocarditis with COVID‐19 infection having normal C‐reactive protein and serial magnetic resonance follow‐up Usui, Eisuke Nagaoka, Eiki Ikeda, Hiroshi Ohmori, Mari Tao, Susumu Yonetsu, Taishi Maejima, Yasuhiro Arai, Hirokuni Amemiya, Kisaki Ikeda, Yoshihiko Sasano, Tetsuo ESC Heart Fail Case Reports A 44‐year‐old woman who was quarantined for 5 days after the diagnosis of coronavirus disease of 2019 (COVID‐19) was transferred to our hospital with the complaint of chest pain. The patient was unvaccinated. Electrocardiography revealed ST elevation in the lateral leads. Echocardiographic biventricular dysfunction with oedematous wall thickening was identified. Cardiac enzyme levels were elevated; however, C‐reactive protein (CRP) levels, and the coronary angiogram were normal. The patient required mechanical circulatory support to stabilize haemodynamics and was treated with remdesivir, baricitinib, and intravenous methylprednisolone. She recovered after 13 days of mechanical support. Serial cardiac magnetic resonance imaging revealed acute myocardial oedema and subsequent fibrosis. An endomyocardial biopsy on admission showed mild interstitial inflammatory infiltrates with endomyocardial fibrous thickening and mild interstitial fibrosis of the myocardium. Normal CRP levels suggested minor involvement of interleukin (IL)‐6, supporting the efficacy of baricitinib. John Wiley and Sons Inc. 2022-11-19 /pmc/articles/PMC10053182/ /pubmed/36401586 http://dx.doi.org/10.1002/ehf2.14228 Text en © 2022 The Authors. ESC Heart Failure published by John Wiley & Sons Ltd on behalf of European Society of Cardiology. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Case Reports
Usui, Eisuke
Nagaoka, Eiki
Ikeda, Hiroshi
Ohmori, Mari
Tao, Susumu
Yonetsu, Taishi
Maejima, Yasuhiro
Arai, Hirokuni
Amemiya, Kisaki
Ikeda, Yoshihiko
Sasano, Tetsuo
Fulminant myocarditis with COVID‐19 infection having normal C‐reactive protein and serial magnetic resonance follow‐up
title Fulminant myocarditis with COVID‐19 infection having normal C‐reactive protein and serial magnetic resonance follow‐up
title_full Fulminant myocarditis with COVID‐19 infection having normal C‐reactive protein and serial magnetic resonance follow‐up
title_fullStr Fulminant myocarditis with COVID‐19 infection having normal C‐reactive protein and serial magnetic resonance follow‐up
title_full_unstemmed Fulminant myocarditis with COVID‐19 infection having normal C‐reactive protein and serial magnetic resonance follow‐up
title_short Fulminant myocarditis with COVID‐19 infection having normal C‐reactive protein and serial magnetic resonance follow‐up
title_sort fulminant myocarditis with covid‐19 infection having normal c‐reactive protein and serial magnetic resonance follow‐up
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10053182/
https://www.ncbi.nlm.nih.gov/pubmed/36401586
http://dx.doi.org/10.1002/ehf2.14228
work_keys_str_mv AT usuieisuke fulminantmyocarditiswithcovid19infectionhavingnormalcreactiveproteinandserialmagneticresonancefollowup
AT nagaokaeiki fulminantmyocarditiswithcovid19infectionhavingnormalcreactiveproteinandserialmagneticresonancefollowup
AT ikedahiroshi fulminantmyocarditiswithcovid19infectionhavingnormalcreactiveproteinandserialmagneticresonancefollowup
AT ohmorimari fulminantmyocarditiswithcovid19infectionhavingnormalcreactiveproteinandserialmagneticresonancefollowup
AT taosusumu fulminantmyocarditiswithcovid19infectionhavingnormalcreactiveproteinandserialmagneticresonancefollowup
AT yonetsutaishi fulminantmyocarditiswithcovid19infectionhavingnormalcreactiveproteinandserialmagneticresonancefollowup
AT maejimayasuhiro fulminantmyocarditiswithcovid19infectionhavingnormalcreactiveproteinandserialmagneticresonancefollowup
AT araihirokuni fulminantmyocarditiswithcovid19infectionhavingnormalcreactiveproteinandserialmagneticresonancefollowup
AT amemiyakisaki fulminantmyocarditiswithcovid19infectionhavingnormalcreactiveproteinandserialmagneticresonancefollowup
AT ikedayoshihiko fulminantmyocarditiswithcovid19infectionhavingnormalcreactiveproteinandserialmagneticresonancefollowup
AT sasanotetsuo fulminantmyocarditiswithcovid19infectionhavingnormalcreactiveproteinandserialmagneticresonancefollowup